Neoplasms of the liver

Modern Pathology

Volumn 20, Issue 1, 2007, Pages 49-60

  Goodman, Zachary D ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

Cholangiocarcinoma; Dysplastic nodule; Hepatocellular adenoma; Hepatocellular carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; HORMONE; IODINATED POPPYSEED OIL; POLYCLONAL ANTISERUM;

BENIGN TUMOR; BILE DUCT; BILE DUCT CARCINOMA; BILE DUCT MALFORMATION; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER SURGERY; CELL DIFFERENTIATION; CHEMOEMBOLIZATION; CHRONIC HEPATITIS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; HISTOPATHOLOGY; HUMAN; IDIOPATHIC DISEASE; IMMUNOHISTOCHEMISTRY; LIVER ADENOMA; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER HISTOLOGY; LIVER RESECTION; LIVER TUMOR; MICROSCOPY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; RADIOFREQUENCY ABLATION; REVIEW; RISK FACTOR; TUMOR CLASSIFICATION; VIRUS HEPATITIS;

ADENOMA, LIVER CELL; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; MALE;

EID: 34248327856     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800682     Document Type: Article

References (34)

1. Ishak KG, Goodman ZD, Stocker JT. Tumors of the Liver and Intrahepatic Bile Ducts. Atlas of Tumor Pathology, Third Series, Fascicle 31. Armed Forces Institute of Pathology: Washington DC, 2001.
2. Pickren JW, Tsukada Y, Lane WW. Liver metastasis: analysis of autopsy data. In: Weiss L, Gilbert HA (eds). Liver Metastasis. GK Hall: Boston, 1982, pp 2-18.
3. Melato M, Laurino L, Mucli E, et al. Relationship between cirrhosis, liver cancer, and hepatic metastases: An autopsy study. Cancer 1989;64:455-459.
4. Bosch FX, Ribes J, Diaz M, et al. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004;127:S5-S16.
5. El-Sarag HB. Hepatocellular carcinoma: recent trends in the US. Gastroenterology 2004;127:S27-S34.
6. Beasley RP. Hepatitis B virus: the major etiology of hepatocellular carcinoma. Cancer 1988;61:1942-1956.
7. Nagasue N, Ito A, Yukaya H, et al. Androgen receptors in hepatocellular carcinoma and surrounding parenchyma. Gastroenterology 1985;89:643-647.
8. Fattovich G, Stroffolini T, Zagni I, et al. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004;127(5 Suppl 1):S35-S50.
9. Fattovich G, Pantalena M, Zagni I, et al. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients. Am J Gastroenterol 2002;97:2886-2895.
10. Morgan TR, Mandayam S, Jamal MM. Alcohol and hepatocellular carcinoma. Gastroenterology 2004;127: S87-S96.
11. Davila JA, Morgan RO, Shaib Y, et al. Diabetes increases the risk of hepatocellular carcinoma in the US: a population based case control study. Gut 2005; 54:533-539.
12. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003;362:1907-1917.
13. Carr BI. Hepatocellular carcinoma: current management and future trends. Gastroenterology 2004; 127L:S218-S224.
14. Craig JR, Peters RL, Edmondson HA, et al. Fibrolamellar carcinoma of the liver. Cancer 1980;46: 372-379.
15. Soreide O, Czemiak A, Bradpiece H, et al. Characteristics of fibrolamellar hepatocellular carcinoma: a study of nine cases and a review of the literature. Am J Surg 1986;151:518-523.
16. Varma V, Cohen C. Immunohistochemical and molecular markers in the diagnosis of hepatocellular carcinoma. Adv Anat Pathol 2004;11:239-249.
17. Minervini MI, Demetris AJ, Lee RG, et al. Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of liver tumors. Mod Pathol 1997;10:686-692.
18. Lugli A, Tornillo L, Mirlacher M, et al. Hepatocyte paraffin 1 expression in human normal and neoplastic tissues: tissue microarray analysis on 3, 940 tissue samples. Am J Clin Pathol 2004;122:721-727.
19. Gouysse G, Frachon S, Hervieu V, et al. Endothelial cell differentiation in hepatocellular adenomas: implications for histopathological diagnosis. J Hepatol 2004;41:259-266.
20. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology 1995;22:983-993.
21. Theise ND, Park YN, Kojiro M. Dysplastic nodules and hepatocarcinogenesis. Clin Liver Dis 2002;6:497-512.
22. Paradis V, Benzekri A, Dargere D, et al. Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. Gastroenterol 2004;126:1323-1329.
23. Hytiroglou P. Morphological changes of early human hepatocarcinogenesis. Semin Liver Dis 2004;24:65-75.
24. Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. Am J Med 1965;38:241-256.
25. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the US. Hepatology 2001;33:1353-1357.
26. Khan SA, Taylor-Robinson SD, Toledano MB, et al Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 2002; 37:806-813.
27. Shaib YH, Davila JA, McGlynn K, et al. Rising incidence of intrahepatic cholangiocarcinoma in the US: a true increase? J Hepatol 2004;40:472-477.
28. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Sem Liver Dis 2004;24:115-124.
29. Lazardidis KN, Gores GJ. Cholangiocarcinoma. Gastroenterology 2005;128:1655-1667.
30. Kobayashi M, Ikeda K, Saitoh S, et al. Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis. Cancer 2000;88:2471-2477.
31. Kagawa Y, Kashihara S, Kuramoto S, et al. Carcinoma arising in a congenitally dilated biliary tract. Report of a case and review of the literature. Gastroenterology 1978;74:1286-1294.
32. Boberg KM, Bergquist A, Mitchell S, et al. Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation. Scand J Gastroenterol 2002;37:1205-1211.
33. Redston MS, Wanless IR. The hepatic von Meyenburg complex with hepatic and renal cyst. Modern Pathol 1996;9:233-237.
34. Bhathal PS, Hughes NR, Goodman ZD. The so-called bile duct adenoma is a peribiliary gland hamartoma. Am J Surg Pathol 1996;20:858-864.